Stay updated with breaking news from Greg Jicha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.
The FDA's landmark decision makes Leqembi more accessible for about 1 million patients across the country.
A Kentucky patient in clinical trials of a 'promising' new Alzheimer's drug at UK's Sanders-Brown Center on Aging says the FDA's recent full approval is among the reasons he participated.
A key antibody treatment in the fight against Alzheimer’s disease, which the University of Kentucky has been studying, just got a full green light from the U.S. Food and Drug
/cloudfront-us-east-1.images.arcpublishing.com/gray/JY4MKLXMCNAAPKNIM5KGBZZMA4.jfif)
On Borkowski made quite an impression in high school when he planted a kiss on a pretty, blonde-haired girl who would later become his wife.